U.S. Life Sciences Stock News

NasdaqGM:RHLD 1 Year Share Price vs Fair Value Explore Resolute Holdings Management's Fair Values from the Community...

NYSE:UCB 1 Year Share Price vs Fair Value Explore United Community Banks's Fair Values from the Community and select...

NasdaqGS:BILI 1 Year Share Price vs Fair Value Explore Bilibili's Fair Values from the Community and select yours...

NasdaqGS:TRST 1 Year Share Price vs Fair Value Explore TrustCo Bank Corp NY's Fair Values from the Community and select...

FS Bancorp ( NASDAQ:FSBW ) Second Quarter 2025 Results Key Financial Results Revenue: US$35.3m (flat on 2Q 2024). Net...

NYSE:NCLH 1 Year Share Price vs Fair Value Explore Norwegian Cruise Line Holdings's Fair Values from the Community and...

Key Insights Given the large stake in the stock by institutions, DHI Group's stock price might be vulnerable to their...

NasdaqGS:BSVN 1 Year Share Price vs Fair Value Explore Bank7's Fair Values from the Community and select yours Bank7...

NYSE:AIR 1 Year Share Price vs Fair Value Explore AAR's Fair Values from the Community and select yours When you buy a...

NasdaqGS:MRTN 1 Year Share Price vs Fair Value Explore Marten Transport's Fair Values from the Community and select...

NasdaqCM:ESQ 1 Year Share Price vs Fair Value Explore Esquire Financial Holdings's Fair Values from the Community and...

Key Insights Significantly high institutional ownership implies Brighthouse Financial's stock price is sensitive to...

First Bancorp ( NASDAQ:FNLC ) Second Quarter 2025 Results Key Financial Results Revenue: US$22.1m (up 18% from 2Q...

Medpace Holdings, Inc. ( NASDAQ:MEDP ) shareholders have had their patience rewarded with a 34% share price jump in the...

NasdaqGS:WSBF 1 Year Share Price vs Fair Value Explore Waterstone Financial's Fair Values from the Community and select...

NYSE:CVLG 1 Year Share Price vs Fair Value Explore Covenant Logistics Group's Fair Values from the Community and select...

NYSE:OKE 1 Year Share Price vs Fair Value Explore ONEOK's Fair Values from the Community and select yours One of the...

Key Insights Ispire Technology's significant private companies ownership suggests that the key decisions are influenced...

Creative Medical Technology Holdings ( NASDAQ:CELZ ) Second Quarter 2025 Results Key Financial Results Net loss...

Many investors define successful investing as beating the market average over the long term. But its virtually certain...

On July 31, 2025, Integra LifeSciences Holdings reported second-quarter financial results, provided updated revenue guidance for the coming quarter and full year, and announced a shelf registration filing to potentially offer US$27.21 million in common stock. This combination of weaker earnings, updated growth expectations, and possible capital raising reflects both ongoing operational challenges and the company's efforts to improve its financial position. We'll examine how the updated...

Meta Platforms reported strong second-quarter 2025 earnings, posting US$47.52 billion in sales and US$18.34 billion in net income, alongside joining the Global Signal Exchange partnership announced by GSE to combat online scams and abuse with Microsoft and over 30 other global companies. The collaboration places Meta at the forefront of industry-wide efforts to address cybercrime at scale, while robust earnings highlight the business momentum from AI-driven user engagement and advertising...

J&J Snack Foods recently reported its third quarter results, highlighting increased sales to US$454.29 million and higher net income of US$44.25 million compared to the previous year, alongside a US$1.5 million intangible asset impairment charge. This combination of top-line growth with an impairment signals both ongoing operational momentum and the impact of one-time expense items on reported earnings. We’ll explore how the positive sales performance, tempered by the impairment charge,...

In the past week, analyst sentiment around Tapestry shifted positively ahead of the upcoming August earnings report, with expectations for higher year-over-year earnings and revenue. This heightened analyst confidence suggests that market participants are responding to Tapestry's perceived potential to outperform consensus EPS estimates, driving renewed attention to the company's results. Now, we'll explore how increased analyst optimism ahead of earnings shapes Tapestry's overall...